Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck & Co., Inc. (NYSE: MRK) and Pfizer Inc. (NYSE: PFE). Merck disappointed by lowering its outlook, although sell-side stayed positive on the prospects.
Presentations at the American Association of Cancer Research Virtual Conference created some volatility. Verastem Inc (NASDAQ: VSTM) became a casualty of "not-so-impressive" clinical data on its Phase 1 asset VS-6766 that targets KRAS mutant advanced solid tumors. The stock shed about 57% to a low of $1.77 before recovering some lost ground.
Here are the key catalysts for the unfolding week.
Conferences
SunTrust Robinson Humphrey 6th Annual Life Sciences Summit (Virtual Conference): May 5–6
Maxim Group M-Vest Infectious Disease Virtual Conference: May 5
Related Link: A Deep Dive On Coronavirus Vaccine Plays Moderna, Inovio
Clinical Readouts
Adverum Biotechnologies Inc (NASDAQ: ADVM) is scheduled to present new data from the OPTIC Phase1 clinical trial of ADVM-022 intravitreal gene therapy in wet age-related macular degeneration. The call discussing the results is scheduled for Monday afternoon.
Auris Medical Holding Ltd (NASDAQ: EARS) is due to release top-line data from the completed Phase 1b AM-201 trial in early May. AM-201 is being evaluated in antipsychotic-induced weight gain.
Early Q2 Schedule
Ovid Therapeutics Inc (NASDAQ: OVID): Phase 2 top-line data for OV101 in Fragile X syndrome
Iterum Therapeutics PLC (NASDAQ: ITRM): Phase 3 data for Sulopenem in uncomplicated and complicated urinary tract infections
Enanta Pharmaceuticals Inc (NASDAQ: ENTA): data from our INTREPID study of EDP-305 in patients with primary biliary cholangitis
Earnings
Monday
• Marinus Pharmaceuticals Inc (NASDAQ: MRNS) (before the market open)
• Minerva Neurosciences Inc (NASDAQ: NERV) (before the market open)
• Epizyme Inc (NASDAQ: EPZM) (before the market open)
• SI-Bone Inc (NASDAQ: SIBN) (after the market close)
• Corcept Therapeutics Incorporated (NASDAQ: CORT) (after the market close)
• Chembio Diagnostics Inc (NASDAQ: CEMI) (after the market close)
• GenMark Diagnostics, Inc (NASDAQ: GNMK) (after the market close)
• Kura Oncology Inc (NASDAQ: KURA) (after the market close)
• Varian Medical Systems, Inc. (NYSE: VAR) (after the market close)
• Fulgent Genetics Inc (NASDAQ: FLGT) (after the market close)
See Also: Inovio Analysts Project About 24% Upside Potential Amid Optimism On Coronavirus DNA Vaccine
Tuesday
• Oxford Immunotec Global PLC (NASDAQ: OXFD) (before the market open)
• Karyopharm Therapeutics Inc (NASDAQ: KPTI) (before the market open)
• Haemonetics Corporation (NYSE: HAE) (before the market open)
• Antares Pharma Inc (NASDAQ: ATRS) (before the market open)
• Harvard Bioscience, Inc. (NASDAQ: HBIO) (before the market open)
• Vericel Corp (NASDAQ: VCEL) (before the market open)
• Regeneron Pharmaceuticals Inc (NASDAQ: REGN) (before the market open)
• Neuronetics Inc (NASDAQ: STIM) (before the market open)
• Mallinckrodt PLC (NYSE: MNK) (before the market open)
• Akebia Therapeutics Inc (NASDAQ: AKBA) (before the market open)
• Agile Therapeutics Inc (NASDAQ: AGRX) (after the market close)
• Aquestive Therapeutics Inc (NASDAQ: AQST) (after the market close)
• Akcea Therapeutics Inc (NASDAQ: AKCA) (after the market close)
• Acorda Therapeutics Inc (NASDAQ: ACOR) (after the market close)
• Axonics Modulation Technologies Inc (NASDAQ: AXNX) (after the market close)
• Synthetic Biologics Inc (NYSE: SYN) (after the market close)
• T2 Biosystems Inc (NASDAQ: TTOO) (after the market close)
• Iovance Biotherapeutics Inc (NASDAQ: IOVA) (after the market close)
• MacroGenics Inc (NASDAQ: MGNX) (after the market close)
• Zogenix, Inc. (NASDAQ: ZGNX) (after the market close)
• Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) (after the market close)
• Exelixis, Inc. (NASDAQ: EXEL) (after the market close)
• Myriad Genetics, Inc. (NASDAQ: MYGN) (after the market close)
• Inspire Medical Systems Inc (NYSE: INSP) (after the market close)
• Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) (after the market close)
• Supernus Pharmaceuticals Inc (NASDAQ: SUPN) (after the market close)
• Nevro Corp (NYSE: NVRO) (after the market close)
• Clovis Oncology Inc (NASDAQ: CLVS) (after the market close)
• InVitae Corp (NYSE: NVTA) (after the market close)
• Cytosorbents Corp (NASDAQ: CTSO) (after the market close)
• Cardiovascular Systems Inc (NASDAQ: CSII) (after the market close)
• Cerus Corporation (NASDAQ: CERS) (after the market close)
• Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) (after the market close)
• Incyte Corporation (NASDAQ: INCY) (after the market close)
• Orthopediatrics Corp (NASDAQ: KIDS) (after the market close)
Wednesday
• Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT) (before the market open)
• Horizon Therapeutics PLC (NASDAQ: HZNP) (before the market open)
• Constellation Pharmaceuticals Inc (NASDAQ: CNST) (before the market open)
• Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) (before the market open)
• IVERIC bio Inc (NASDAQ: ISEE) (before the market open)
• Blueprint Medicines Corp (NASDAQ: BPMC) (before the market open)
• BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) (before the market open)
• Strongbridge Biopharma plc (NASDAQ: SBBP) (before the market open)
• Evofem Biosciences, Inc. (NASDAQ: EVFM) (before the market open)
• Neurocrine Biosciences, Inc. (NASDAQ: NBIX) (before the market open)
• Jounce Therapeutics Inc (NASDAQ: JNCE) (before the market open)
• PPD Inc (NASDAQ: PPD) (before the market open)
• Zoetis Inc (NYSE: ZTS) (before the market open)
• Ionis Pharmaceuticals Inc (NASDAQ: IONS) (before the market open)
• TherapeuticsMD Inc (NASDAQ: TXMD) (before the market open)
• Avanos Medical Inc (NYSE: AVNS) (before the market open)
• Aerie Pharmaceuticals Inc (NASDAQ: AERI) (after the close)
• Allogene Therapeutics Inc (NASDAQ: ALLO) (after the close)
• ADMA Biologics Inc (NASDAQ: ADMA) (after the close)
• Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) (after the close)
• AxoGen, Inc Common Stock (NASDAQ: AXGN) (after the close)
• Global Blood Therapeutics Inc (NASDAQ: GBT) (after the close)
• Pacific Biosciences of California (NASDAQ: PACB) (after the close)
• Theravance Biopharma Inc (NASDAQ: TBPH) (after the close)
• BioTelemetry Inc (NASDAQ: BEAT) (after the close)
• Bio-Rad Laboratories, Inc. (NYSE: BIO) (after the close)
• Veracyte Inc (NASDAQ: VCYT) (after the close)
• Ligand Pharmaceuticals Inc. (NASDAQ: LGND) (after the close)
• Precigen Inc (NASDAQ: PGEN) (after the close)
• Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) (after the close)
• OraSure Technologies, Inc. (NASDAQ: OSUR) (after the close)
• NuVasive, Inc. (NASDAQ: NUVA) (after the close)
• Sarepta Therapeutics Inc (NASDAQ: SRPT) (after the close)
• Natera Inc (NASDAQ: NTRA) (after the close)
• Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) (after the close)
• Qiagen NV (NYSE: QGEN) (after the close)
• Enanta Pharmaceuticals Inc (NASDAQ: ENTA) (after the close)
• Esperion Therapeutics Inc (NASDAQ: ESPR) (after the close)
• G1 Therapeutics Inc (NASDAQ: GTHX) (after the close)
• Quidel Corporation (NASDAQ: QDEL) (after the close)
• Cytokinetics, Inc. (NASDAQ: CYTK) (after the close)
• MannKind Corporation (NASDAQ: MNKD) (after the close)
Thursday
• Integra Lifesciences Holdings Corp (NASDAQ: IART) (before the market open)
• Intra-Cellular Therapies Inc (NASDAQ: ITCI) (before the market open)
• Endo International PLC (NASDAQ: ENDP) (before the market open)
• Xeris Pharmaceuticals Inc (NASDAQ: XERS) (before the market open)
• Moderna Inc (NASDAQ: MRNA) (before the market open)
• Syros Pharmaceuticals Inc (NASDAQ: SYRS) (before the market open)
• Elanco Animal Health Inc (NYSE: ELAN) (before the market open)
• Athenex Inc (NASDAQ: ATNX) (before the market open)
• Aldeyra Therapeutics Inc (NASDAQ: ALDX) (before the market open)
• Albireo Pharma Inc (NASDAQ: ALBO) (before the market open)
• ANI Pharmaceuticals Inc (NASDAQ: ANIP) (before the market open)
• Agenus Inc (NASDAQ: AGEN) (before the market open)
• Amicus Therapeutics, Inc. (NASDAQ: FOLD) (before the market open)
• Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) (before the market open)
• Bristol-Myers Squibb Co (NYSE: BMY) (before the market open)
• Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) (before the market open)
• X4 Pharmaceuticals Inc (NASDAQ: XFOR) (before the market open)
• Miragen Therapeutics Inc (NASDAQ: MGEN) (before the market open)
• Kala Pharmaceuticals Inc (NASDAQ: KALA) (before the market open)
• Seres Therapeutics Inc (NASDAQ: MCRB) (before the market open)
• Intellia Therapeutics Inc (NASDAQ: NTLA) (before the market open)
• Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) (before the market open)
• Editas Medicine Inc (NASDAQ: EDIT) (before the market open)
• Pacira Biosciences Inc (NASDAQ: PCRX) (before the market open)
• Syndax Pharmaceuticals Inc (NASDAQ: SNDX) (after the close)
• Tricida Inc (NASDAQ: TCDA) (after the close)
• Helius Medical Technologies Inc (NASDAQ: HSDT) (after the close)
• Twist Bioscience Corp (NASDAQ: TWST) (after the close)
• Athersys Inc (NASDAQ: ATHX) (after the close)
• Accelerate Diagnostics Inc (NASDAQ: AXDX) (after the close)
• Adamas Pharmaceuticals Inc (NASDAQ: ADMS) (after the close)
• Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) (after the close)
• Anika Therapeutics Inc (NASDAQ: ANIK) (after the close)
• Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) (after the close)
• ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) (after the close)
• Calithera Biosciences Inc (NASDAQ: CALA) (after the close)
• BioDelivery Sciences International, Inc. (NASDAQ: BDSI) (after the close)
• Puma Biotechnology Inc (NASDAQ: PBYI) (after the close)
• Coherus Biosciences Inc (NASDAQ: CHRS) (after the close)
• Kindred Biosciences Inc (NASDAQ: KIN) (after the close)
• PDL BioPharma Inc (NASDAQ: PDLI) (after the close)
• Rockwell Medical Inc (NASDAQ: RMTI) (after the close)
• Penumbra Inc (NYSE: PEN) (after the close)
• Pfenex Inc (NYSE: PFNX) (after the close)
• ZIOPHARM Oncology Inc. (NASDAQ: ZIOP) (after the close)
• NovaBay Pharmaceuticals, Inc. (NYSE: NBY) (after the close)
• ICU Medical Inc (NASDAQ: ICUI) (after the close)
• Nektar Therapeutics (NASDAQ: NKTR) (after the close)
• Savara Inc (NASDAQ: SVRA) (after the close)
• Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) (after the close)
• OptiNose Inc (NASDAQ: OPTN) (after the close)
• Eloxx Pharmaceuticals Inc (NASDAQ: ELOX) (after the close)
• Five Prime Therapeutics Inc (NASDAQ: FPRX) (after the close)
• Flexion Therapeutics Inc (NASDAQ: FLXN) (after the close)
• FibroGen Inc (NASDAQ: FGEN) (after the close)
• Globus Medical Inc (NYSE: GMED) (after the close)
• Guardant Health Inc (NASDAQ: GH) (after the close)
• OpGen Inc (NASDAQ: OPGN) (after the close)
• Lineage Cell Therapeutics Inc (NYSE: LCTX) (after the close)
• Dynavax Technologies Corporation (NASDAQ: DVAX) (after the close)
• Chiasma Inc (NASDAQ: CHMA) (after the close)
• Collegium Pharmaceutical Inc (NASDAQ: COLL) (after the close)
• Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) (after the close)
• Caladrius Biosciences Inc (NASDAQ: CLBS) (after the close)
• Glaukos Corp (NYSE: GKOS) (after the close)
• Celcuity Inc (NASDAQ: CELC) (after the close)
• Codexis, Inc. (NASDAQ: CDXS) (after the close)
• CytomX Therapeutics Inc (NASDAQ: CTMX) (after the close)
• Insulet Corporation (NASDAQ: PODD) (after the close)
Friday
• Meridian Bioscience, Inc. (NASDAQ: VIVO) (before the market open)
• Mersana Therapeutics Inc (NASDAQ: MRSN) (before the market open)
• Ocular Therapeutix Inc (NASDAQ: OCUL) (before the market open)
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
"flow" - Google News
May 03, 2020 at 07:45PM
https://ift.tt/2VXb0Cm
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace - Benzinga
"flow" - Google News
https://ift.tt/2Sw6Z5O
https://ift.tt/2zNW3tO
Bagikan Berita Ini
0 Response to "The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace - Benzinga"
Post a Comment